TDP-2

CC(=O)NC(CO)CC(=O)C1=CC=C2OC(C)(C)CC(=O)C2=C1N

InChIKey=VXRAAUKUZQYZRW-UHFFFAOYSA-N

InChI=1S/C17H22N2O5/c1-9(21)19-10(8-20)6-12(22)11-4-5-14-15(16(11)18)13(23)7-17(2,3)24-14/h4-5,10,20H,6-8,18H2,1-3H3,(H,19,21)

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Targets

Primary Target	Pharmacology	Condition	Potency
lymphocyte proliferation 2 Target ID: GO:0046651 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1344894	Modulator 846

PubMed

Title	Date	PubMed
Immunomodulatory effects of fusarochromanones TDP-1 and TDP-2.	1992	1344894
Immunochromatography of fusarochromanone mycotoxins.	1991-07-01	1917812
Biosynthesis of fusarochromanone and its monoacetyl derivative by Fusarium equiseti.	1989-04	2729980

Substance Class	Chemical Created by `admin` on `Tue Apr 01 19:51:39 GMT 2025` Edited by `admin` on `Tue Apr 01 19:51:39 GMT 2025`
Record UNII	7FAJ6I3CI0
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

MONOACETYLFUSAROCHROMANONE

Preferred Name

English

TDP-2

Common Name

English

ACETAMIDE, N-(3-(5-AMINO-3,4-DIHYDRO-2,2-DIMETHYL-4-OXO-2H-1-BENZOPYRAN-6-YL)-1-(HYDROXYMETHYL)-3-OXOPROPYL)-

Systematic Name

English

Code System Code Type Description

CAS

120976-97-8

Created by admin on Tue Apr 01 19:51:39 GMT 2025 , Edited by admin on Tue Apr 01 19:51:39 GMT 2025

PRIMARY

EPA CompTox

DTXSID301108680

Created by admin on Tue Apr 01 19:51:39 GMT 2025 , Edited by admin on Tue Apr 01 19:51:39 GMT 2025

PRIMARY

FDA UNII

7FAJ6I3CI0

Created by admin on Tue Apr 01 19:51:39 GMT 2025 , Edited by admin on Tue Apr 01 19:51:39 GMT 2025

PRIMARY

PUBCHEM

102571616

Created by admin on Tue Apr 01 19:51:39 GMT 2025 , Edited by admin on Tue Apr 01 19:51:39 GMT 2025

PRIMARY